Advertisement
Bridion (sugammadex) has been approved by the U.S. Food and Drug Administration to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide.

FDA Approves Bridion to Reverse Neuromuscular Blockade

0
Drug reverses the effects of rocuronium bromide and vecuronium bromide
The top 10 percent of Medicare prescribers account for more than 50 percent of opioid claims

Distribution of Opioid Prescribing ID’d for Different Providers

0
Top 10 percent of Medicare prescribers account for 56.7 percent of opioid claims
Stroke risk appears to more than double in the first week following a shingles diagnosis

Risk of CV Events Up After Shingles Diagnosis in Seniors

0
Chance of stroke, myocardial infarction increased most in the first week after diagnosis
Platelet counts rise among patients with chronic hepatitis C virus infection who experience a sustained virological response to antiviral therapy

Platelet Counts Rise With Viral Response to Hep C Therapy

0
Change in platelets correlated with change in spleen size after antiviral therapy for chronic HCV
A recent survey of pediatric anesthesia programs at teaching institutions in the United States highlights the need for improvements in training

Neurotoxicity of Anesthesia in Children Needs to Be Addressed

0
Survey suggests need for improvements in clinical practice, training, and communication on this topic
Antidepressant use during the second and third trimesters of pregnancy may increase the risk for autism spectrum disorder in offspring

Antidepressant Use in Pregnancy Tied to ASD Risk in Offspring

0
Antidepressant use in second or third trimester linked to 87 percent increased ASD risk
Conventional non-pharmacologic and pharmacologic options for the management of opioid-induced constipation in pregnancy are often ineffective or cause potentially troublesome adverse effects

Opioid-Related Constipation Tx Suboptimal in Pregnancy

0
PAMORA strategy appears to safe with superior effectiveness
Omalizumab appears to be highly effective for the management of severe allergic asthma

Omalizumab Highly Effective for Severe Allergic Asthma

0
Review of "real-life" studies shows improvements across objective and subjective burden of illness
Twenty percent aluminum chloride hexahydrate reduces axillary sweating more effectively than 1 percent aluminum acetate

Greater Sweat Reduction for Aluminum Chloride Hexahydrate

0
Twenty percent aluminum chloride hexahydrate more effective than 1 percent aluminum acetate
For patients with major depressive disorder

CYP2C19 Polymorphisms Impacts Citalopram Metabolism

0
CYP2C19*2 polymorphism seems to contribute to interindividual variability in CIT metabolism